Proprietary Technology Platform: JBIO leverages a unique and innovative proprietary technology platform for drug discovery and development, enabling more efficient identification of novel therapeutic candidates and potential for first-in-class treatments.

Robust Intellectual Property Portfolio: JBIO possesses a strong and growing portfolio of patents, trade secrets, and exclusive licenses covering its core technologies, drug candidates, and applications, providing significant barriers to entry for competitors.

Experienced Scientific Leadership: JBIO is led by a highly experienced team of scientists, researchers, and executives with deep expertise in biosciences, drug development, and regulatory affairs, ensuring rigorous scientific execution and strategic guidance.